Bio-Techne Corporation (TECH) |
|
243.9 -1.33 (-0.54%)
|
09-20 01:41 |
|
Open: |
247.23 |
Pre. Close: |
245.23 |
|
High:
|
247.5035 |
Low:
|
240.925 |
|
Volume:
|
344,009 |
Market Cap:
|
9,404M |
|
|
|
|
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. The company is headquartered in Minneapolis, Minnesota and currently employs 2,250 full-time employees. The firm operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
247.814 - 249.018 |
249.018 - 250.205 |
|
Low:
|
237.388 - 238.896 |
238.896 - 240.383 |
|
Close:
|
241.088 - 243.495 |
243.495 - 245.868 |
|
Technical analysis |
as of: 2020-09-18 4:36:11 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 301.17 One year: 313.85 |
| Support: |
Support1: 240.28 Support2: 199.91 |
| Resistance: |
Resistance1: 257.85 Resistance2: 268.71 |
| Pivot: |
249.11  |
| Moving Average: |
MA(5): 245.34  MA(20): 250.08
MA(100): 260.07 MA(250): 226.57 |
| MACD: |
MACD(12,26): -4.72 Signal(9): -4.56 |
| Stochastic oscillator: |
%K(14,3): 17.69 %D(3): 18.79 |
| RSI: |
RSI(14): 38.08 |
| 52-week: |
High: 286.68 Low: 155.17 Change(%): 20.6 |
| Average Vol(K): |
3-Month: 16078 10-Days: 16589 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.TECH has closed above bottom band by 25.3%. Bollinger Bands are 31.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 17 Sep 2020
Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership - PRNewswire
Tue, 08 Sep 2020
Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise Awareness And Education To Empower Men With Prostate Cancer - PRNewswire
Tue, 08 Sep 2020
BIO-TECHNE Corp (NASDAQ:TECH) Expected to Post Quarterly Sales of $185.70 Million - MarketBeat
Thu, 03 Sep 2020
Bio-Techne To Present At The 2020 Wells Fargo Virtual Healthcare Conference - Yahoo Finance
Thu, 27 Aug 2020
There’s Reason For Concern Over Bio-Techne Corporation’s (NASDAQ:TECH) Price - Simply Wall St
Sun, 23 Aug 2020
BIO-TECHNE Corp (NASDAQ:TECH) Sees Significant Growth in Short Interest - MarketBeat
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
38 |
| Shares Float (M) |
38 |
|
% Held by Insiders
|
0.49 |
|
% Held by Institutions
|
94.32 |
|
Shares Short (K)
|
637 |
|
Shares Short P. Month (K)
|
618 |
Stock Financials |
|
EPS
|
5.820 |
|
EPS Est This Year
|
3.990 |
|
EPS Est Next Year
|
4.390 |
|
Book Value (p.s.)
|
35.920 |
|
Profit Margin
|
31.04 |
|
Operating Margin
|
20.41 |
|
Return on Assets (ttm)
|
4.8 |
|
Return on Equity (ttm)
|
18.0 |
|
Qtrly Rev. Growth
|
-8.3 |
|
Gross Profit (p.s.)
|
12.642 |
|
Sales Per Share
|
19.327 |
|
EBITDA (p.s.)
|
5.207 |
|
Qtrly Earnings Growth
|
257.50 |
|
Operating Cash Flow (M)
|
205 |
|
Levered Free Cash Flow (M)
|
141 |
Stock Valuations |
|
PE Ratio
|
41.91 |
|
PEG Ratio
|
3.28 |
|
Price to Book value
|
6.79 |
|
Price to Sales
|
12.62 |
|
Price to Cash Flow
|
45.42 |
Stock Dividends |
|
Dividend
|
1.280 |
|
Forward Dividend
|
1.280 |
|
Dividend Yield
|
0.01 |
|
Dividend Pay Date
|
2020-08-27 |
|
Ex-Dividend Date
|
2020-08-16 |
|
7 Binary Options
|
|
Your Ad Here
|
|
